Ran Tian
- Molecular Biology top 10%
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Oncology top 10%
- Cancer Research top 10%
- Topics
- Nanoplatforms for cancer theranostics (11 papers)Nanoparticle-Based Drug Delivery (6 papers)S100 Proteins and Annexins (5 papers)
- Journals
- Proceedings of the National Academy of SciencesAdvanced MaterialsSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ran Tian
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.0k
- Biomedical Engineering 460
- Biomaterials 384
- Oncology 320
- Cancer Research 270
Countries citing papers authored by Ran Tian
This map shows the geographic impact of Ran Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Tian more than expected).
Fields of papers citing papers by Ran Tian
This network shows the impact of papers produced by Ran Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Tian. The network helps show where Ran Tian may publish in the future.
Co-authorship network of co-authors of Ran Tian
This figure shows the co-authorship network connecting the top 25 collaborators of Ran Tian. A scholar is included among the top collaborators of Ran Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Tian. Ran Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 81 | |
| 2 | 8 | |
| 3 | 21 | |
| 4 | 52 | |
| 5 | 81 | |
| 6 | 42 | |
| 7 | 19 | |
| 8 | 18 | |
| 9 | 8 | |
| 10 | 129 | |
| 11 | 38 | |
| 12 | 25 | |
| 13 | 171 | |
| 14 | 130 | |
| 15 | 22 | |
| 16 | 19 | |
| 17 | 57 | |
| 18 | 60 | |
| 19 | 97 | |
| 20 | 24 |
About Ran Tian
Ran Tian is a scholar working on Toxicology, Biomaterials and Cancer Research, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (6 papers) and S100 Proteins and Annexins (5 papers). The work is most often cited by research in Biomaterials (384 citations), Molecular Medicine (100 citations) and Cancer Research (270 citations). Ran Tian has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ruifang Niu, Xin Chen, Fei Zhang, Wei Ji, Pingyun Yuan, Shiyu Liu, Maureen E. Balestra, Yadong Huang, R. Dennis Miranda and Shengjun Chang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.